Kimberly Scott
Nurse Practitioner · Virginia Beach, VANPI 1104822295
Payments from drug & device makers
Across 122 payments — averaging $24.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$773
- GSK$474
- Regeneron Healthcare Solutions, Inc.$470
- Inspire Medical Systems, Inc.$324
- Sanofi$267
- Aerin Medical Inc.$190
- plus $448 from 12 others
Across 2 payments — averaging $375.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$750
What the payments were for
- Food & beverage$2,947100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 59 | $773 |
| GSK | 18 | $474 |
| Regeneron Healthcare Solutions, Inc. | 17 | $470 |
| Inspire Medical Systems, Inc. | 1 | $324 |
| Sanofi | 10 | $267 |
| Aerin Medical Inc. | 2 | $190 |
| KARL Storz Endoscopy-america | 1 | $101 |
| Alk-abello, Inc | 1 | $75 |
| Novartis | 3 | $61 |
| Hikma Pharmaceuticals USA | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 1 | $31 |
| Phadia US Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| Mentor Worldwide LLC | 1 | $24 |
| Kaleo, Inc. | 1 | $23 |
| AstraZeneca | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Intersect ENT, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,947 in reported general payments places this provider in the 90th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QnaslBeclomethasone Dipropionate | 13 | $7,266 |
| Azelastine Hcl | 203 | $7,138 |
| Fluticasone Propionate | 281 | $5,785 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 24 | $4,091 |
| Mometasone Furoate | 54 | $3,453 |
| Montelukast Sodium | 258 | $3,255 |
| Levocetirizine Dihydrochloride | 259 | $3,213 |
| Ipratropium Bromide | 58 | $3,065 |
| Desloratadine | 75 | $2,817 |
| Olopatadine Hcl | 16 | $2,461 |
| Dexlansoprazole DrDexlansoprazole | 11 | $2,285 |
| Ofloxacin | 51 | $2,125 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $1,983 |
| Fluocinolone Acetonide Oil | 34 | $1,664 |
| Prednisone | 86 | $1,265 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Virginia Beach
- Sasha LeeVirginia Beach$32K
- Kristin AustriaVirginia Beach$26K
- Kimberly ClovisVirginia Beach$14K
- Lisa WalkerVirginia Beach$11K
- Barbara McCrayVirginia Beach$10K
- Matthew GilbertVirginia Beach$10K
- Colette BrooksVirginia Beach$9K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.